TCRT Alaunos Therapeutics, Inc. Company Short-Term Debt

alaunos.com - graphic logo of issuer TCRT

The stability of Alaunos Therapeutics (TCRT) is being undermined by rapid capital burn and fierce sector competition, as well as the potential for trial failures due to toxicity. Alaunos Therapeutics is currently undergoing a period of stagnation and restructuring, requiring external financing to advance its TCR-T projects. Market price action with the 0.00 indicator reflects a company developing a closed lymphocyte modification system based on Sleeping Beauty.

TCRT Alaunos Short-Term Debt (07/04/2022 - 10/31/2026)

Analytical breakdowns and data insights for company Alaunos Therapeutics Inc. (TCRT)

- current quotes and average value forecast:
Price Chart Alaunos|TCRT - Average Forecast Price
- market capitalization data:
Market Value Alaunos Therapeutics, Inc.|TCRT - Total Company Value
- shareholders' equity book value data:
Net Assets per Single Share Alaunos Therapeutics|TCRT - Total Stockholders' Equity|Market Capitalization to Book Value Ratio alaunos.com|TCRT - Company Balance Sheet Assets
- company total debt and liquidity indicators:
Total Debt to Equity Ratio Alaunos Therapeutics|TCRT - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Alaunos|TCRT - Aggregate Debt Obligations|Debts to Book Capitalization Alaunos Therapeutics, Inc.|TCRT - Company Long-Term Liabilities|Company Short-Term Debts Alaunos Therapeutics|Quick Liquidity alaunos.com
- earnings and multiples data:
TCRT - Company Net Income
General company analysis:alaunos.com (TCRT)
Flagship merchandise of Alaunos Therapeutics

A comparative analysis of short-term liabilities allows an investor to assess the operational liquidity buffer via the ratio of current liabilities to liquid assets. This metric measures the risk of default in the absence of revenue, which is critical for Alaunos Therapeutics (TCRT) during its resource conservation phase, reflecting business resilience within the short-term debt history.

Competitor analysis

LEGN - Company Short-Term Debt|Short-Term Debt Sana Biotechnology Inc|Autolus Pharma (AUTL) - Company Short-Term Debt|ALLO (Allogene Corp) - Company Short-Term Debt|Company Short-Term Debt Cartesian Therapeutics|Short-Term Debt Cellectis Biotherapeutics CLLS|Company Short-Term Debts CRBU|Instil Bio Inc. (TIL) - Short-Term Indebtedness|Genenta Science - Company Current Liabilities|Century Tx (IPSC) - Short-Term Debt|JSPR: Company Current Liabilities|Company Short-Term Loans and Borrowings SNTI (Senti Biosciences, Inc.)|ADAP: Company Short-Term Debts|Company Current Liabilities CERo Therapeutics Holdings|ACHL (Achilles Therapeutics PLC) - Company Short-Term Debts|Short-Term Debt CARGO Therapeutics, Inc CRGX|Company Short-Term Debt Poseida Therapeutics (PSTX)|Company Short-Term Debt TSVT (2seventybio.com)|Company Short-Term Debt Gracell Biotechnologies Inc. GRCL